In our case, immunohistochemistry for FGFR1 on the ovarian neoplasm was not performed, so we have no evidence that this could be a second lesion secreting FGF23 in addition to the PMT in the pertrochanteric region. Here, FGF23 is linked to ovarian neoplasm.